Director, Wills Eye Retina Service
Ophthalmology
Dr. Carl D. Regillo, MD
|
|
Give Review
Carl Regillo practices Ophthalmology. He researched medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He over the years received 31 awards: "America's Top Doctors", "Philadelphia Magazine", "150 Top Innovators", "Top Docs", "Top Physicians", "Top Doctors", "Speaker of the Day", "Best Doctors", "Best Poster", "Secretariat Award", "Senior Honor Award", "Senior Achievement Award", "Honor Award", "Achievement Award", "Navy Commendation Medal-Ophthalmology Dept", "M. Weiner Annual Award-Outstanding Clinical Teaching in Ophthalmology", "Top Performer-Medical Officer Training School", "James S. Shipman Award-Best resident research presentation", "Valedictorian", "Presidents Awards", "Hodgkinson Memorial Award", "Roche Laboratories Award", "Sears B. Condit Award", "Phi Kappa Phi Award and Honor Society", "Rho Chi Scholarship Award and Honor Society", "Sousa Memorial Award", "Dean Keagle Scholarship", "Super Doctor", "Fellow (FAAO)", "Heed Ophthalmic Foundation Fellowship" and "Fellow (FACS)". Carl D. Regillo, MD is a published MD. He has 84 papers published. The most current publication "Evaluating persistent and recurrent choroidal neovascularization. The role of indocyanine green angiography." Carl Regillo accepts Medicare payments and is registered with Medicare.gov.
Publications
- Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease.
- Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
- Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients with Wet Age-Related Macular Degeneration.
- Characterization of Anatomic and Visual Function Outcomes in Patients With Full-Thickness Macular Hole in Ocriplasmin Phase 3 Trials.
- Efficacy of Intravitreal Ocriplasmin on VitreoMacular Traction and Full-Thickness Macular Holes.
- Speculum versus Bimanual Lid Retraction during Intravitreal Injection.
- PROSPECTIVE EVALUATION OF VISUAL ACUITY AGREEMENT BETWEEN STANDARD EARLY TREATMENT Diabetic RETINOPATHY STUDY CHART AND A HANDHELD EQUIVALENT IN EYES WITH RETINAL PATH...
- Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related Macular degeneration and Stargardt's Macular dystrophy: follow-up of two open...
- Baseline Choroidal Thickness as a Predictor for Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema.
- Three Year Treatment Outcomes for Neovascular Age-Related Macular Degeneration using a "Treat and Extend" Regimen.
- Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration.
- Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials.
- Optic Neuropathy after Vitrectomy for Retinal Detachment: Clinical Features and Analysis of Risk Factors.
- Preferred therapies for Neovascular age-related macular degeneration.
- Ranibizumab for Eyes Previously Treated With Pegaptanib or Bevacizumab Without Clinical Response.
- Bevacizumab for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen: Clinical and Economic Impact.
- ASSOCIATION BETWEEN HIGH-RISK Disease LOCI AND RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION.
- Iatrogrenic Retinal breaks.
- 23-Gauge Transconjunctival Pars Plana Vitrectomy for Removal of Retained Lens Fragments.
- Management of Retinal Vasoproliferative Tumor Associated with ROP by Plaque Brachytherapy.
- A treat and extend regimen using ranibizumab for Neovascular age-related macular degeneration clinical and economic impact.
- Analysis of six genetic risk factors Highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26.
- The Microsurgical Safety Task Force: evolving guidelines for minimizing the risk of Endophthalmitis associated with microincisional vitrectomy surgery.
- Ranibizumab for exudative age-related Macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors.
- Incidence of Endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
- Metallic intraocular foreign bodies: characteristics, interventions, and prognostic factors for visual outcome and Globe survival.
- Short-term outcomes of 23-gauge pars plana vitrectomy.
- Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes.
- Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated Retinal detachment.
- Randomized, double-masked, sham-controlled trial of ranibizumab for Neovascular age-related macular degeneration: PIER Study year 1.
- Intravitreal bevacizumab (avastin) in central Retinal vein occlusion.
- Anti-VEGF agents in the treatment of Neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients.
- Pegaptanib for Choroidal neovascularization in treatment-naïve exudative age-related macular degeneration.
- Postoperative complications associated with 25-gauge pars plana vitrectomy.
- Clinical safety profile of posterior juxtascleral depot administration of anecortave acetate 15 mg suspension as primary therapy or adjunctive therapy with photodynami...
- Intraoperative sclerotomy-related retinal breaks for Macular surgery, 20- vs 25-gauge vitrectomy systems.
- Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolates.
- Laser treatment for Retinopathy of prematurity: evolution in treatment technique over 15 years.
- Macular exudative retinal detachment in a patient with a dural cavernous sinus fistula.
- Photodynamic therapy in young patients.
- Evaluation of the potential acuity meter in predicting visual acuity after photodynamic therapy for Choroidal neovascularization.
- Determination of the incidence and clinical characteristics of subsequent retinal tears following treatment of the Acute posterior vitreous detachment-related initial ...
- A review of treatments for Macular degeneration: a synopsis of currently approved treatments and ongoing clinical trials.
- Infectious and presumed noninfectious Endophthalmitis after intravitreal triamcinolone acetonide injection.
- The histopathologic effects of transpupillary thermOtherapy in human eyes.
- Management of subMacular hemorrhage.
- A comparison of laser photocoagulation with cryOtherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome.
- A comparison of laser photocoagulation with cryOtherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome.
- Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related Macular degeneration.
- Ocular manifestations of graft versus host Disease.
- Intravitreal triamcinolone acetonide for Diabetic macular edema.
- Progress in the management of major retinal Disorders: highlights from the 2008 Sally Letson Symposium.
- Repair of retinitis-related Retinal detachments with silicone oil in patients with acquired immunodeficiency syndrome.
- Ocular tuberculosis.
- Free radicals and lipid peroxidation in ethanol- or aspirin-induced gastric mucosal injury.
- Indocyanine green angiography and occult Choroidal neovascularization.
- Advanced proliferative retinopathy and iris Neovascularization in an intravenous drug abuser.
- Diabetic papillopathy. Patient characteristics and fundus findings.
- Color Doppler hemodynamics of giant cell arteritis.
- Successful scleral buckling procedures decrease central Retinal artery blood flow velocity.
- Hemodynamic alterations in the Acute retinal necrosis syndrome.
- Surgical management of complications associated with X-linked retinoschisis.
- Histopathologic findings in congenital grouped pigmentation of the Retina.
- Outcomes of vitrectomy for retained Lens fragments.
- Indocyanine green angiography of idiopathic polypoidal Choroidal vasculopathy.
- A small-incision technique for suturing a posterior chamber intraocular Lens.
- Choroidal hematopoiesis in an adult.
- A comparison of laser photocoagulation with trans-scleral cryOtherapy in the treatment of threshold retinopathy of prematurity.
- Evaluating persistent and recurrent Choroidal neovascularization. The role of indocyanine green angiography.
- Surgical management of retinoschisis.
- Visual outcomes after laser photocoagulation for threshold Retinopathy of prematurity.
- Management of subMacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
- The present role of indocyanine green angiography in ophthalmology.
- Transient visual loss and decreased Ocular blood flow velocities following a scleral buckling procedure.
- Visual outcomes following the use of intravitreal steroids in the treatment of postoperative Endophthalmitis.
- Update on photodynamic therapy.
- Diabetes and Retinopathy.
- Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes.
- Bungee cord-associated Ocular trauma.
- Treatment of subRetinal hemorrhages with tissue plasminogen activator.
- Hypopyon uveitis in immunocompetent patients treated for Mycobacterium avium complex pulmonary infection with rifabutin.
- Patient-initiated second medical opinions: their necessity and economic cost.
- Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: a retrospective review.
Schools
Harvard Medical School
Brigham and Women39s Hospital
Wills Eye Hospital
Northeastern University
Procedures Preformed
- Cataract Removal Surgery
- Destruction of Lesion of Retina and Choroid
- Enucleation of Eye
- Eye Examination
- View All
Conditions Treated
- Acute Endophthalmitis
- Anterior Ischemic Optic Neuropathy
- Aphakia and Other Disorders of Lens
- Benign Neoplasm of Choroid
- View All
Doctors Specialties
- Ophthalmology
- Retinal Diseases
Accepted Insurances
Awards
- America's Top Doctors
- Philadelphia Magazine
- 150 Top Innovators
- Top Doc’s
- Top Physicians
- Top Doctors
- Speaker of the Day
- Best Doctors
- Best Poster
- Secretariat Award
- Senior Honor Award
- Senior Achievement Award
- Honor Award
- Achievement Award
- Navy Commendation Medal-Ophthalmology Dept
- M. Weiner Annual Award-Outstanding Clinical Teaching in Ophthalmology
- Top Performer-Medical Officer Training School
- James S. Shipman Award-Best resident research presentation
- Valedictorian
- President’s Awards
- Hodgkinson Memorial Award
- Roche Laboratories Award
- Sears B. Condit Award
- Phi Kappa Phi Award and Honor Society
- Rho Chi Scholarship Award and Honor Society
- Sousa Memorial Award
- Dean Keagle Scholarship
- Super Doctor
- Fellow (FAAO)
- Heed Ophthalmic Foundation Fellowship
- Fellow (FACS)
Education
-
Wills Eye Hospital -
Harvard Medical School
Hospital
-
Thomas Jefferson University Hospital -
Cooper University Health Care
Drug Facts
| NPI NUMBER | 1740248038 | |
| NPPES Provider LastName | REGILLO | |
| NPPES Provider FirstName | CARL | |
| NPPES Provider ZIPCode | 190387910 | |
| NPPES Provider State | PA | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 595.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1740248038 |
| Last Name Of The Provider | REGILLO |
| First Name Of The Provider | CARL |
| View All |
Similar Doctors
|
Dr. Gary C. Brown, MD |
|
|
Dr. Joseph I. Maguire, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James F. Vander, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchell S. Fineman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunir J. Garg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa J. Linder, MD
This Doctor is OpenDoctor Recommended.
|